In patients, both anti-CTLA4 therapy and anti-PD1 therapy similarly increased T cell clonality in the tumor (190), but the extent of clonal expansion in the tumor pre-treatment was only predictive of outcome following anti-PD1 therapy (190). Here, CTLA4 is linked to neoplasm.